Yue Clare Lou, PhD
Founder and CEO
Sift Biosciences
Dr. Yue Clare Lou is a microbiologist with over a decade of research experience applying large-scale genomic sequencing and computational biology to characterize immune responses shaped by microbial exposure. Her work focuses on translating these insights into novel therapeutics for immune-related diseases. Dr. Lou earned her PhD from UC Berkeley under the mentorship of Dr. Jill Banfield. In 2023, she was selected as an Entrepreneurial Fellow at UC Berkeley and subsequently awarded a $1M non-dilutive grant in 2024 to launch Sift Biosciences, a biotech company developing peptide-based immunotherapies that harness microbial immunity to treat cancer and autoimmune disease. Dr. Lou's contributions to the life sciences have been recognized by Forbes 30 Under 30, the American Cancer Society's BrightEdge Fellowship, and the Termeer Fellowship.
Sessions
-
23-Jun-20265BSift Biosciences
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}